Market Overview:
The Global Unit Drug Dose Delivery System Market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for unit dose drug delivery systems due to their benefits such as improved patient compliance, reduced medication errors, and increased efficiency in hospitals and clinics. In addition, the growing prevalence of chronic diseases is also contributing to the growth of this market. Based on type, the global unit drug dose delivery system market can be segmented into blister packaging, pre-fillable syringes & cartridges, vials & ampoules, and others (pouches, sticks). The blister packaging segment is expected to account for the largest share of this market in 2018 owing to its advantages such as tamper-evident seals that prevent tampering with medications and ease of use. By application, hospitals are expected to account for the largest share of this market in 2018 followed by clinics.
Product Definition:
Unit Drug Dose Delivery System is a system that delivers a specific dose of medication to a patient. This system is important because it helps to ensure that patients receive the correct dose of medication.
Blister Packaging:
Blister packaging is a method of drug packaging in which the dose is divided into numerous small containers or blisters, each containing a single dose. The blisters are made from paper or plastic and are filled with the drug substance. They are then sealed using an adhesive, usually located on the edge of one of the blisters.
Pre-fillable Syringes & Catridges:
Pre-fillable syringes & catridges are used in unit drug dose delivery systems. They are also known as auto-injectors or pen injectors. Prefilled syringes and catridges help to reduce the time required for drug administration, thereby increasing its efficiency.
Application Insights:
Based on application, the global unit drug dose delivery system market is segmented into hospitals and clinics. The hospitals segment dominated the market in 2017 owing to factors such as increasing hospital admissions for infectious diseases and an increase in patients suffering from chronic conditions requiring long-term medication management. This trend is expected to continue over the forecast period due to ongoing initiatives by public and private organizations aimed at improving healthcare infrastructure across developing countries, which, in turn, will drive demand for UDDDS systems.
The clinics segment are anticipated to witness lucrative growth over the forecast period owing to factors such as growing awareness about health issues among a wider population along with rising incidences of diabetes that require regular medical follow-ups and appointments at clinics or walk-in centers. Growing demand for UDDDS systems among primary healthcare providers is also expected fuel industry expansion during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as favorable reimbursement policies, high healthcare expenditure, and increasing incidence of infectious diseases. Moreover, the presence of major players in this region is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising geriatric population and awareness about vaccination programs among people living in rural areas as well as urban centers. The government initiatives for immunization drives are also contributing toward increased demand for UD dose delivery systems across this region. For instance, according to data published by Worldometers Pte Ltd., India’s immunization program covered around 9 out of 10 children under age 5 years with at least one vaccine (diphtheria-tetanus-pertussis vaccine). Such coverage levels are further boosting product demand across Asia Pacific countries such as India and China that account for a large share of unmet medical needs within their respective regions worldwide.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 7.8% from 2016 to 2021. This is primarily due to the increasing number of geriatric population, rising prevalence of chronic diseases, and technological advancements in surgical procedures. Unit drug dose delivery systems are widely used in minimally invasive surgeries as they offer several benefits such as reduced blood loss, shorter hospital stay, and faster recovery time.
- Growing demand for targeted drug delivery: The global market for targeted drug delivery is expected to grow at a CAGR of 9% from 2016 to 2021. This can be attributed to the growing prevalence of chronic diseases such as cancer and diabetes, increasing R&D expenditure by pharmaceutical companies on novel therapeutics targeting specific organs or tissues, and rising awareness about the benefits of targeted drug delivery over conventional therapies. Unit dose drug delivery systems play an important role in targeted drug delivery by providing accurate dosing and reducing systemic exposure to drugs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Unit Drug Dose Delivery System Market Research Report
By Type
Blister Packaging, Pre-fillable Syringes & Catridges, Vials & Ampoules, Others (Pouches, Sticks)
By Application
Hospitals, Clinics
By Companies
Amcor Limited, Amcor, Wipak Group, Schott AG., Nipro Corporation, Gerresheimer, West Pharmaceutical Services, R-Pharm Germany GmbH, Agrado S.A, Constantia Flexibles Group, Amcor Limited, Klockner Pentaplast Group, Catalent, Inc., Huhtamaki Oyj., Omnicell, Inc., Piramal Glass Limited, O.Berk Company, LLC, SGD Pharma.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Unit Drug Dose Delivery System Market Report Segments:
The global Unit Drug Dose Delivery System market is segmented on the basis of:
Types
Blister Packaging, Pre-fillable Syringes & Catridges, Vials & Ampoules, Others (Pouches, Sticks)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amcor Limited
- Amcor
- Wipak Group
- Schott AG.
- Nipro Corporation
- Gerresheimer
- West Pharmaceutical Services
- R-Pharm Germany GmbH
- Agrado S.A
- Constantia Flexibles Group
- Amcor Limited
- Klockner Pentaplast Group
- Catalent, Inc.
- Huhtamaki Oyj.
- Omnicell, Inc.
- Piramal Glass Limited
- O.Berk Company, LLC
- SGD Pharma.
Highlights of The Unit Drug Dose Delivery System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blister Packaging
- Pre-fillable Syringes & Catridges
- Vials & Ampoules
- Others (Pouches, Sticks)
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Unit Drug Dose Delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Unit Drug Dose Delivery System (UDDS) is a device that helps to accurately deliver a prescribed dose of medication to the patient. UDDSs can be either self-administered or administered by another person.
Some of the major companies in the unit drug dose delivery system market are Amcor Limited, Amcor, Wipak Group, Schott AG., Nipro Corporation, Gerresheimer, West Pharmaceutical Services, R-Pharm Germany GmbH, Agrado S.A, Constantia Flexibles Group, Amcor Limited, Klockner Pentaplast Group, Catalent, Inc., Huhtamaki Oyj., Omnicell, Inc., Piramal Glass Limited, O.Berk Company, LLC, SGD Pharma..
The unit drug dose delivery system market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Unit Drug Dose Delivery System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Unit Drug Dose Delivery System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Unit Drug Dose Delivery System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Unit Drug Dose Delivery System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Unit Drug Dose Delivery System Market Size & Forecast, 2018-2028
4.5.1 Unit Drug Dose Delivery System Market Size and Y-o-Y Growth
4.5.2 Unit Drug Dose Delivery System Market Absolute $ Opportunity
Chapter 5 Global Unit Drug Dose Delivery System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Unit Drug Dose Delivery System Market Size Forecast by Type
5.2.1 Blister Packaging
5.2.2 Pre-fillable Syringes & Catridges
5.2.3 Vials & Ampoules
5.2.4 Others (Pouches
5.2.5 Sticks)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Unit Drug Dose Delivery System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Unit Drug Dose Delivery System Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Unit Drug Dose Delivery System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Unit Drug Dose Delivery System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Unit Drug Dose Delivery System Analysis and Forecast
9.1 Introduction
9.2 North America Unit Drug Dose Delivery System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Unit Drug Dose Delivery System Market Size Forecast by Type
9.6.1 Blister Packaging
9.6.2 Pre-fillable Syringes & Catridges
9.6.3 Vials & Ampoules
9.6.4 Others (Pouches
9.6.5 Sticks)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Unit Drug Dose Delivery System Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Unit Drug Dose Delivery System Analysis and Forecast
10.1 Introduction
10.2 Europe Unit Drug Dose Delivery System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Unit Drug Dose Delivery System Market Size Forecast by Type
10.6.1 Blister Packaging
10.6.2 Pre-fillable Syringes & Catridges
10.6.3 Vials & Ampoules
10.6.4 Others (Pouches
10.6.5 Sticks)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Unit Drug Dose Delivery System Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Unit Drug Dose Delivery System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Unit Drug Dose Delivery System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Unit Drug Dose Delivery System Market Size Forecast by Type
11.6.1 Blister Packaging
11.6.2 Pre-fillable Syringes & Catridges
11.6.3 Vials & Ampoules
11.6.4 Others (Pouches
11.6.5 Sticks)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Unit Drug Dose Delivery System Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Unit Drug Dose Delivery System Analysis and Forecast
12.1 Introduction
12.2 Latin America Unit Drug Dose Delivery System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Unit Drug Dose Delivery System Market Size Forecast by Type
12.6.1 Blister Packaging
12.6.2 Pre-fillable Syringes & Catridges
12.6.3 Vials & Ampoules
12.6.4 Others (Pouches
12.6.5 Sticks)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Unit Drug Dose Delivery System Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Unit Drug Dose Delivery System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Unit Drug Dose Delivery System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Unit Drug Dose Delivery System Market Size Forecast by Type
13.6.1 Blister Packaging
13.6.2 Pre-fillable Syringes & Catridges
13.6.3 Vials & Ampoules
13.6.4 Others (Pouches
13.6.5 Sticks)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Unit Drug Dose Delivery System Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Unit Drug Dose Delivery System Market: Competitive Dashboard
14.2 Global Unit Drug Dose Delivery System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amcor Limited
14.3.2 Amcor
14.3.3 Wipak Group
14.3.4 Schott AG.
14.3.5 Nipro Corporation
14.3.6 Gerresheimer
14.3.7 West Pharmaceutical Services
14.3.8 R-Pharm Germany GmbH
14.3.9 Agrado S.A
14.3.10 Constantia Flexibles Group
14.3.11 Amcor Limited
14.3.12 Klockner Pentaplast Group
14.3.13 Catalent, Inc.
14.3.14 Huhtamaki Oyj.
14.3.15 Omnicell, Inc.
14.3.16 Piramal Glass Limited
14.3.17 O.Berk Company, LLC
14.3.18 SGD Pharma.
